EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 337 filers reported holding EXELIXIS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296 | +10.9% | 13,535 | -3.1% | 0.00% | 0.0% |
| Q2 2023 | $267 | -66.1% | 13,965 | -65.6% | 0.00% | -75.0% |
| Q1 2023 | $788 | +200.8% | 40,608 | +149.0% | 0.00% | +300.0% |
| Q4 2022 | $262 | -100.0% | 16,306 | -84.6% | 0.00% | -88.9% |
| Q3 2022 | $1,661,000 | +313.2% | 105,939 | +448.0% | 0.01% | +350.0% |
| Q2 2022 | $402,000 | -33.7% | 19,331 | -27.6% | 0.00% | -33.3% |
| Q1 2022 | $606,000 | +17.2% | 26,714 | -5.5% | 0.00% | +50.0% |
| Q4 2021 | $517,000 | -13.4% | 28,273 | +0.1% | 0.00% | -33.3% |
| Q3 2021 | $597,000 | -6.7% | 28,231 | -19.6% | 0.00% | 0.0% |
| Q2 2021 | $640,000 | -74.9% | 35,126 | -68.8% | 0.00% | -78.6% |
| Q1 2021 | $2,546,000 | +49.1% | 112,714 | +32.4% | 0.01% | +40.0% |
| Q4 2020 | $1,708,000 | 0.0% | 85,123 | +21.8% | 0.01% | -16.7% |
| Q3 2020 | $1,708,000 | +12.5% | 69,871 | +9.2% | 0.01% | +9.1% |
| Q2 2020 | $1,518,000 | +36.3% | 63,957 | -1.1% | 0.01% | 0.0% |
| Q1 2020 | $1,114,000 | +13.3% | 64,694 | +16.0% | 0.01% | +37.5% |
| Q4 2019 | $983,000 | +12.9% | 55,771 | +13.3% | 0.01% | 0.0% |
| Q3 2019 | $871,000 | -10.9% | 49,226 | +7.5% | 0.01% | -11.1% |
| Q2 2019 | $978,000 | +74.6% | 45,786 | +94.5% | 0.01% | +80.0% |
| Q1 2019 | $560,000 | +41.4% | 23,541 | +17.1% | 0.01% | +25.0% |
| Q4 2018 | $396,000 | -4.8% | 20,110 | -14.4% | 0.00% | 0.0% |
| Q3 2018 | $416,000 | -3.7% | 23,496 | +17.1% | 0.00% | -20.0% |
| Q2 2018 | $432,000 | +7.5% | 20,068 | +10.5% | 0.01% | 0.0% |
| Q1 2018 | $402,000 | -9.9% | 18,165 | +23.8% | 0.01% | 0.0% |
| Q4 2017 | $446,000 | +7.7% | 14,669 | -14.1% | 0.01% | -16.7% |
| Q3 2017 | $414,000 | +24.0% | 17,075 | +25.8% | 0.01% | +20.0% |
| Q2 2017 | $334,000 | +98.8% | 13,573 | +20.4% | 0.01% | +66.7% |
| Q4 2016 | $168,000 | -20.8% | 11,270 | -32.0% | 0.00% | -25.0% |
| Q3 2016 | $212,000 | – | 16,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |